China gave the greenlight to Eli Lilly & Co.’s blockbuster drug tirzepatide for use in treating diabetes, a move that will ...
Eli Lilly And Company (NYSE:LLY) announced that Chinese regulators have approved its diabetes drug tirzepatide. This approval ...
SHANGHAI (Reuters) - Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, ...
Innovent has scored another phase 3 win for mazdutide as the drug showed its superiority to Eli Lilly's diabetes and heart drug Trulicity when it came to glycemic control in patients with Type 2 ...
Eli Lilly drug tirzepatide, marketed as Zepbound for weight management, has results from two Phase 3 studies showing reductions in the breathing problems caused by obstructive sleep apnea.
(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential ceiling for new weight-loss drugs even further in the eyes of analysts and investors. Most Read ...
(Reuters) -Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, ...
, opens new tab to market its blockbuster obesity treatment drugs in India, the company's CEO said on Friday. 'Absolutely and always open...we value our partnership with Lilly tremendously and I ...
Pharma major Cipla has reported a consolidated net profit of Rs 939 crore for the January to March period, up 79 percent year-on-year (YoY), compared with Rs 525.6 crore in the year-ago period.
EXCLUSIVETwist in case of missing teenager who left a chilling note on her pillow and vanished from her Texas home... as mom ...